Interestingly, recent data demonstrated that CD8+ T cells with specificities against conserved peptides amongst a variety of coronaviruses are much more abundant in COVID-19 patients with a mild disease versus those with a more severe disease, which is suggestive for a protective role (83). The gene discussed is CD8A; the disease is COVID-19.